Endocrinology News

Age at menarche has fallen among U.S. women during the past 55 years while time to menstrual cycle regularity has increased, both troubling signs that indicate worsening health outcomes over time, researchers reported.

The National Lipid Association Scientific Sessions will be held Thursday to Sunday and will spotlight emerging areas of research such as “cardio-rheumatology,” a renewed push to reinstate LDL as a health system quality metric and more.

All women with vs. without premenstrual disorders had higher risk for suicide, whereas those diagnosed at younger than 25 years had increased all-cause mortality risk, according to study results published in JAMA Network Open.

In two phase 2b trials, RNA interference agents were associated with reductions in triglycerides compared with placebo for patients with mixed hyperlipidemia.

Older adults with type 1 or type 2 diabetes who sustain an incident hip fracture have a similar likelihood for a subsequent hip fracture as those without diabetes, according to study data published in Bone.

A new study in the Journal of Osteopathic Medicine showed that higher BMIs before pregnancy correlated with increasing risks for maternal and neonatal morbidity.

Use of the drug semaglutide in patients with type 2 diabetes significantly reduced the risk of major kidney disease events, cardiovascular outcomes and all-cause mortality vs. placebo, newly published data show.

Vosoritide was associated with increased annualized height velocity for children with five different genetic causes of short stature, according to study findings.

An FDA committee declined to recommend approval for a once-weekly insulin to improve glycemic control for adults with type 1 diabetes.

The FDA authorized a closed-loop algorithm for an artificial pancreas system for use by people with type 1 diabetes aged 2 years and older, including during pregnancy, according to press release from Cambridge University.